Citations 465

Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia

European Journal of Neurology | December 16, 2013 | Volume: 21 | Issue: 7 | Pages: 1040-1043

10.1111/ene.12331 | PMID 24330306

Background and purposeA subset of patients with Alzheimer's disease (AD) present with early and prominent language deficits. It is unclear whether the burden of underlying β‐amyloid pathology is associated with language or general cognitive impairment in these subjects.MethodsThe relationship between cortical β‐amyloid burden on [11C]Pittsburgh compound B (PiB) positron emission tomography (PET) and performance on the Montreal Cognitive Assessment (MoCA), the Wechsler Memory Scale − Third Edition (WMS‐III), the Boston Naming Test (BNT) and the Western Aphasia Battery (WAB) was assessed using regression and correlation analyses in subjects presenting with aphasia who showed β‐amyloid deposition on PiB PET.ResultsThe global PiB ratio was inversely correlated with MoCA (P = 0.02) and the WMS‐III Visual Reproduction (VR) subtest (VR I, P = 0.02; VR II, P = 0.04). However, the correlations between PiB ratio, BNT (P = 0.13), WAB aphasia quotient (P = 0.11) and WAB repetition scores (P = 0.34) were not significant.ConclusionThis study demonstrates that an increased cortical β‐amyloid burden is associated with cognitive impairment, but not language deficits, in AD subjects presenting with aphasia. The results suggest that β‐amyloid deposition could be partly contributing to impaired cognition in such patients whilst language dysfunction may be more influenced by other pathological mechanisms, perhaps downstream pathways of β‐amyloid deposition.
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

Neurology | October 18, 2013 | Volume: 81 | Issue: 20 | Pages: 1732-1740

10.1212/01.wnl.0000435556.21319.e4 | PMID 24132377

MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies

Neurology | October 11, 2013 | Volume: 81 | Issue: 19 | Pages: 1681-1689

10.1212/01.wnl.0000435299.57153.f0 | PMID 24107861

IC‐P‐067: Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.064

P2–120: Antemortem MRI findings associated with presence of microinfarcts at autopsy

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2013.05.764

IC‐P‐058: Antemortem MRI findings associated with presence of microinfarcts at autopsy

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.054

IC‐P‐102: Hypometabolism in PiB‐positive, population‐based, cognitively normal subjects with and without APOE‐ɛ4

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2013.05.099

O1–03–02: Focal hemosiderin deposits and beta‐amyloid load in the ADNI cohort

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2013.04.062

O2–02–04: Hypometabolism in PiB‐positive, population‐based, cognitively normal subjects with and without APOE‐ε4

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2013.04.144

P3–217: Effect of intellectual lifestyle and Alzheimer's disease biomarkers on rate of cognitive decline: Mayo Clinic Study of Aging

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2013.05.1290